Cytoskeleton: The mother of all actins?
There was a time when most scientists believed that eukaryotes had cytoskeletons and that bacteria and archaea did not. This view changed in the early 1990s when a bacterial protein – that was later identified as a tubulin homolog – was shown to form a ring-like structure that is essential for bacterial cells to divide (Bi and Lutkenhaus, 1991; Mukherjee and Lutkenhaus, 1994). It has since been discovered that bacteria and archaea carry homologs for all the components of the eukaryotic cytoskeleton – actin, tubulin and intermediate filaments (Shih and Rothfield, 2006). What is more, we now know that many of these homologs form complex filamentous structures and fulfill similar roles to the cytoskeleton of eukaryotes. This indicates that the cytoskeleton most likely evolved further back in the history of life on Earth than originally thought.
The first eukaryotic cells are thought to have originated after an archaeal cell engulfed an ancient bacterium and the two established a symbiotic relationship (Rivera et al., 1998; Yutin et al., 2008). An archaeon called Pyrobaculum calidifontis is believed to be one of the closest living relatives of the ancestral archaea involved in this event (Guy and Ettema, 2011), and has been studied by many researchers. A key component in the cytoskeleton of P. calidifontis – a protein called crenactin – is a homolog of actin. While crenactin is only ~20% identical to eukaryotic actin, of all the proteins found outside of the eukaryotes, it is the one that is most closely related to actin (Ettema et al., 2011).
Two years ago, Jan Löwe, Thierry Izoré and colleagues at the MRC Laboratory of Molecular Biology reported that the crystal structure of crenactin was similar to that of eukaryotic actin in many respects (Figure 1). However, while actin forms double-stranded filaments, crenactin appeared to form only single-stranded helices (Izoré et al., 2014). Using electron cryo-microscopy, another group later reported that crenactin also forms single-stranded helices in solution (Braun et al., 2015).
Now, in eLife, Löwe and colleagues – including Izoré as first author – have used electron cryo-microscopy to further investigate the structure of crenactin filaments (Izoré et al., 2016). However, contrary to the previous reports, Izoré et al. now show that crenactin filaments are more similar to actin filaments than previously thought. Indeed, both form parallel, double-stranded filaments with a similar helical arrangement, and the individual subunits in a crenactin filament interact like those in an actin filament.
Izoré et al. note that the earlier studies used salt concentrations much higher than the concentrations that P. calidifontis needs to grow. Although the salt concentration inside this bacterium is not known so far, they suggest that this could have interfered with how the filaments formed and could thus explain the discrepancy between the previous and new results. The double-stranded filaments also seem to be more stable than the single-stranded crenactin filaments. This meant that Izoré et al. could, for the first time, study crenactin filaments in enough detail to be able to distinguish their finer features.
The strong resemblance between actin and crenactin suggests that actin has looked much like it does today since early on in the evolution of eukaryotes. Interestingly, actin is required for phagocytosis, the process by which a eukaryotic cell engulfs a bacterium. As mentioned above, it is thought a similar mechanism gave rise to the first eukaryotes (Yutin et al., 2009), and the presence of a working actin-like cytoskeleton in the ancestral archaea would certainly support this idea.
The gene encoding crenactin is part of a group of five genes called the arcade cluster that are found within the genomes of the Crenarchaeota (Ettema et al., 2011). This is the group of archaea to which P. caldifontis belongs and which gives crenactin its name. In P. caldifontis, three proteins encoded by other genes in the arcade cluster – called arcadin-1, -3, and -4 – localize with crenactin filaments inside cells, hinting that they might interact. In contrast, arcadin-2 does not co-localize with filaments (Ettema et al., 2011).
Izoré et al. also report that the C-terminal region of arcadin-2 strongly interacts with individual crenactin proteins, effectively sequestering them and preventing them from polymerizing to form filaments. In turn, this explains why arcadin-2 has a different distribution pattern to the other arcadins. Izoré et al. then went on to show, using X-ray crystallography, that a fragment of arcadin-2 encompassing its C-terminal portion folds into a helix and binds to crenactin. The binding site corresponds to a site on actin that is used by eukaryotic proteins involved in disassembling filaments.
Further experiments showed that arcadin-1 interacted very poorly with the individual crenactin proteins. However, considering its distribution in the cell, it is still possible that arcadin-1 prefers to interact with filaments rather than individual proteins.
Izoré et al. report that the structure of arcadin-1 does not look like any other known protein structure, meaning that it represents a new protein fold. They also note that the primary sequence of arcadin-2 is unlike that of any actin regulator known to date. This suggests that while the actin cytoskeleton might predate the first eukaryotes, its regulation has been invented independently during evolution. The fact that several, evolutionarily-unrelated proteins use similar mechanisms to fine-tune the polymerization state of actin provides further support for this idea.
All in all, the discoveries of Löwe, Izoré and colleagues highlight the remarkable level of complexity in the cytoskeletons of non-eukaryotes. Moreover, the continuous development of microbiology guarantees that this picture is going to become ever more complex. Hopefully, these advances will bring us even closer to understanding the evolution of the cytoskeleton.
References
-
An actin-based cytoskeleton in archaeaMolecular Microbiology 80:1052–1061.https://doi.org/10.1111/j.1365-2958.2011.07635.x
-
The archaeal 'TACK' superphylum and the origin of eukaryotesTrends in Microbiology 19:580–587.https://doi.org/10.1016/j.tim.2011.09.002
-
Guanine nucleotide-dependent assembly of FtsZ into filamentsJournal of Bacteriology 176:2754–2758.https://doi.org/10.1128/jb.176.9.2754-2758.1994
-
The bacterial cytoskeletonMicrobiology and Molecular Biology Reviews 70:729–754.https://doi.org/10.1128/MMBR.00017-06
-
The deep archaeal roots of eukaryotesMolecular Biology and Evolution 25:1619–1630.https://doi.org/10.1093/molbev/msn108
Article and author information
Author details
Publication history
Copyright
© 2016, Merino et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,222
- views
-
- 290
- downloads
-
- 3
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Chromosomes and Gene Expression
- Structural Biology and Molecular Biophysics
Type II nuclear receptors (T2NRs) require heterodimerization with a common partner, the retinoid X receptor (RXR), to bind cognate DNA recognition sites in chromatin. Based on previous biochemical and overexpression studies, binding of T2NRs to chromatin is proposed to be regulated by competition for a limiting pool of the core RXR subunit. However, this mechanism has not yet been tested for endogenous proteins in live cells. Using single-molecule tracking (SMT) and proximity-assisted photoactivation (PAPA), we monitored interactions between endogenously tagged RXR and retinoic acid receptor (RAR) in live cells. Unexpectedly, we find that higher expression of RAR, but not RXR, increases heterodimerization and chromatin binding in U2OS cells. This surprising finding indicates the limiting factor is not RXR but likely its cadre of obligate dimer binding partners. SMT and PAPA thus provide a direct way to probe which components are functionally limiting within a complex TF interaction network providing new insights into mechanisms of gene regulation in vivo with implications for drug development targeting nuclear receptors.
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
The SARS-CoV-2 main protease (Mpro or Nsp5) is critical for production of viral proteins during infection and, like many viral proteases, also targets host proteins to subvert their cellular functions. Here, we show that the human tRNA methyltransferase TRMT1 is recognized and cleaved by SARS-CoV-2 Mpro. TRMT1 installs the N2,N2-dimethylguanosine (m2,2G) modification on mammalian tRNAs, which promotes cellular protein synthesis and redox homeostasis. We find that Mpro can cleave endogenous TRMT1 in human cell lysate, resulting in removal of the TRMT1 zinc finger domain. Evolutionary analysis shows the TRMT1 cleavage site is highly conserved in mammals, except in Muroidea, where TRMT1 is likely resistant to cleavage. TRMT1 proteolysis results in reduced tRNA binding and elimination of tRNA methyltransferase activity. We also determined the structure of an Mpro-TRMT1 peptide complex that shows how TRMT1 engages the Mpro active site in an uncommon substrate binding conformation. Finally, enzymology and molecular dynamics simulations indicate that kinetic discrimination occurs during a later step of Mpro-mediated proteolysis following substrate binding. Together, these data provide new insights into substrate recognition by SARS-CoV-2 Mpro that could help guide future antiviral therapeutic development and show how proteolysis of TRMT1 during SARS-CoV-2 infection impairs both TRMT1 tRNA binding and tRNA modification activity to disrupt host translation and potentially impact COVID-19 pathogenesis or phenotypes.